4.6 Editorial Material

The Prodromal Microbiome

期刊

MOVEMENT DISORDERS
卷 33, 期 1, 页码 5-7

出版社

WILEY
DOI: 10.1002/mds.27197

关键词

-

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Clinical Neurology

Individual parkinsonian motor signs and striatal dopamine transporter deficiency: a study with [I-123]FP-CIT SPECT

Elina Makinen, Juho Joutsa, Elina Jaakkola, Tommi Noponen, Jarkko Johansson, Miia Pitkonen, Reeta Levo, Tuomas Mertsalmi, Filip Scheperjans, Valtteri Kaasinen

JOURNAL OF NEUROLOGY (2019)

Article Clinical Neurology

Deep brain stimulation for dystonia in Finland during 2007-2016

Rebekka M. Ortiz, Filip Scheperjans, Eero Pekkonen

BMC NEUROLOGY (2019)

Article Clinical Neurology

Burden of non-motor symptoms in unclear parkinsonism and tremor: A study with [123I]FP-CIT SPECT

Elina Jaakkola, Juho Joutsa, Elina Makinen, Tommi Noponen, Miia Pitkonen, Reeta Levo, Tuomas Mertsalmi, Filip Scheperjans, Valtteri Kaasinen

JOURNAL OF THE NEUROLOGICAL SCIENCES (2019)

Review Neurosciences

Increasing Comparability and Utility of Gut Microbiome Studies in Parkinson's Disease: A Systematic Review

Jeffrey M. Boertien, Pedro A. B. Pereira, Velma T. E. Aho, Filip Scheperjans

JOURNAL OF PARKINSONS DISEASE (2019)

Article Clinical Neurology

Antibiotic exposure and risk of Parkinson's disease in finland: A nationwide case-control study

Tuomas H. Mertsalmi, Eero Pekkonen, Filip Scheperjans

MOVEMENT DISORDERS (2020)

Article Neurosciences

Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson's disease

Velma T. E. Aho, Madelyn C. Houser, Pedro A. B. Pereira, Jianjun Chang, Knut Rudi, Lars Paulin, Vicki Hertzberg, Petri Auvinen, Malu G. Tansey, Filip Scheperjans

Summary: This study found that intestinal inflammatory responses and reductions in fecal SCFAs occur in Parkinson's disease (PD), are related to the microbiota and to disease onset, and are not reflected in plasma inflammatory profiles. Some of these relationships are distinct in PD and are sex-dependent. This study revealed potential alterations in microbiota-host interactions and links between earlier PD onset and intestinal inflammatory responses and reduced SCFA levels.

MOLECULAR NEURODEGENERATION (2021)

Article Neurosciences

Gut bacterial tyrosine decarboxylase associates with clinical variables in a longitudinal cohort study of Parkinsons disease

Sebastiaan P. van Kessel, Petri Auvinen, Filip Scheperjans, Sahar El Aidy

Summary: The gut microbiota plays a role in the clinical response of orally administered drugs, particularly in the case of tyrosine decarboxylating (TDC) bacteria and Parkinson's disease medication. Exposure to anti-PD medication may affect the abundance of bacterial TDC gene, potentially impacting drug efficacy. Further research is needed to understand the effects of anti-PD medication on microbial changes and gastrointestinal function.

NPJ PARKINSONS DISEASE (2021)

Article Neurosciences

Multiomics implicate gut microbiota in altered lipid and energy metabolism in Parkinson's disease

Pedro A. B. Pereira, Drupad K. Trivedi, Justin Silverman, Ilhan Cem Duru, Lars Paulin, Petri Auvinen, Filip Scheperjans

Summary: This study investigated the link between serum metabolites, gut bacterial community composition, and clinical variables in Parkinson's disease (PD) and healthy control subjects (HC). The results showed alterations in serum metabolite profiles in PD, and suggested that several bacterial taxa are associated with altered lipid and energy metabolism in PD.

NPJ PARKINSONS DISEASE (2022)

Article Health Care Sciences & Services

Real-Life Experience on Directional Deep Brain Stimulation in Patients with Advanced Parkinson's Disease

Maija Koivu, Filip Scheperjans, Johanna Eerola-Rautio, Nuutti Vartiainen, Julio Resendiz-Nieves, Riku Kivisaari, Eero Pekkonen

Summary: Directional deep brain stimulation (dDBS) is effective in reducing both motor and non-motor symptoms in advanced Parkinson's disease patients, with minimal adverse effects in real-life clinical care.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Review Clinical Neurology

Gut microbiota dysbiosis in Parkinson disease: A systematic review and pooled analysis

Sven Kleine Bardenhorst, Emanuele Cereda, Marco Severgnini, Michela Barichella, Gianni Pezzoli, Ali Keshavarzian, Alessandro Desideri, Daniele Pietrucci, Velma T. E. Aho, Filip Scheperjans, Falk Hildebrand, Severin Weis, Markus Egert, Andre Karch, Marius Vital, Nicole Ruebsamen

Summary: The aim of this study is to reduce methodological heterogeneity in Parkinson's disease (PD) research and perform a pooled analysis. The results show that harmonizing workflows minimizes differences between statistical methods and reveals a small set of taxa associated with PD. Increased shares of Akkermansia and Bifidobacterium and decreased shares of Roseburia and Faecalibacterium are characteristic of PD-associated microbiota.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

Meeting Abstract Clinical Neurology

Functional Bowel Symptoms in Parkinson's Disease

K. Murtomaki, T. Mertsalmi, E. Jaakkola, E. Makinen, J. Joutsa, R. Levo, E. Pekkonen, V. Kaasinen, F. Scheperjans

MOVEMENT DISORDERS (2019)

Meeting Abstract Clinical Neurology

Glabellar tap predicts dopamine transporter deficiency in parkinsonism

S. Nuuttila, J. Joutsa, M. Eklund, E. Jaakkola, E. Makinen, T. Noponen, T. Ihalainen, F. Scheperjans, V. Kaasinen

MOVEMENT DISORDERS (2019)

Meeting Abstract Clinical Neurology

Task Specific Dystonia and Its Response to Botulinum Neurotoxin Treatment

R. Ortiz, T. Mertsalmi, F. Scheperjans, E. Pekkonen

MOVEMENT DISORDERS (2019)

Meeting Abstract Clinical Neurology

Local anesthesia vs general anesthesia in STN-dDBS operation: a clinical comparison of the outcome of patients with advanced Parkinson's disease

M. Koivu, J. Resendiz-Nieves, J. Eerola-Rautio, F. Scheperjans, R. Kivisaari, E. Pekkonen

MOVEMENT DISORDERS (2019)

Meeting Abstract Clinical Neurology

Striatal dopaminergic regulation of micrographia in parkinsonism

M. Eklund, J. Joutsa, S. Nuuttila, E. Makinen, E. Jaakkola, T. Noponen, T. Ihalainen, M. Koivisto, S. Teperi, F. Scheperjans, V. Kaasinen

MOVEMENT DISORDERS (2019)

暂无数据